Orofacial Granulomatosis (OFG) and Melkersson-Rosenthal Syndrome (MRS) represent rare, chronic conditions that affect the orofacial region. OFG is characterised by persistent or recurrent soft tissue ... Please provide your email address to receive an email when new articles are posted on .

Understanding the Context

After 1 year, 38 out of 56 patients no longer needed oral corticosteroids. The proportion of patients ... Oral health is a key indicator of overall health, well-being and quality of life. It encompasses a range of diseases and conditions that include dental caries, Periodontal disease, Tooth loss, Oral cancer, Oral manifestations of HIV infection, Oro-dental trauma, Noma and birth defects such as cleft lip and palate.

Key Insights

The Global Burden of Disease Study 2017 estimated that oral diseases affect 3.5 ... A fact sheet on oral contraceptives which provides detail on their effectiveness, health benefits and risks and side effects as well as WHO's work in this area. The World Health Organization has released a new global guideline, Environmentally friendly and less invasive oral health care for preventing and managing dental caries. The guideline provides evidence-based recommendations to support countries in preventing and managing dental caries through environmentally sustainable and less invasive approaches that promote patient safety, quality of care ... Delegations from over 110 countries are coming together to produce national roadmaps and negotiate a joint declaration on oral health at the first-ever global oral health meeting organized by the World Health Organization (WHO).

Final Thoughts

The declaration is expected to outline collective commitments from Member States to accelerate the implementation of the Global action plan on oral health 2023–2030. Oral health is a key indicator of overall health, well-being and quality of life. It encompasses a range of diseases and conditions that include dental caries, Periodontal disease, Tooth loss, Oral cancer, Oral manifestations of HIV infection, Oro-dental trauma, Noma and birth defects such as cleft lip and palate. The novel oral polio vaccine (nOPV2) is currently in the wider use roll-out phase under WHO Emergency Use Listing (EUL) for the control of type 2 circulating vaccine-derived poliovirus (cVDPV2) outbreaks, in line with the Strategic Advisory Group of Experts on Immu nization (SAGE) guidance.